Debut, a vertically integrated biotechnology company, has announced that it has signed an agreement with L'Oréal to develop more than a dozen vital, bio-identical ingredients that will replace conventionally sourced ingredients currently used in L'Oréal global beauty and personal care brands across skin, hair, color cosmetics and fragrance. As part of the agreement, Debut will create new bio-based ingredients using proprietary advanced bio-manufacturing processes which combine fermentation and cell-free technology to replace conventional methods.
Green sciences such as Debut's breakthrough biotechnology processes unlock a new generation of cosmetic bioactive ingredients and products that marry the best of nature with supply chain transparency, safety, purity, consistency, quality and science-backed data. "Creating bio-identical ingredients at scale helps preserve global biodiversity and secure responsible ingredient supply chains while continuing to prioritize quality and product performance," says Joshua Britton, Ph.D., founder and CEO of Debut. "Debut is committed to creating bio-based formulations for all its beauty products and has unmatched capabilities in biotechnology, formulation, and scaling to catalyze this transformative shift in beauty."